Baillie Gifford - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$344,062,043
-27.5%
8,340,898
-1.9%
0.31%
-22.3%
Q2 2023$474,877,153
-2.8%
8,504,247
-2.9%
0.40%
-8.4%
Q1 2023$488,384,935
+55.8%
8,753,987
+1.8%
0.44%
+34.9%
Q4 2022$313,465,444
+30.4%
8,602,235
+1.9%
0.33%
+31.9%
Q3 2022$240,467,000
-36.6%
8,443,388
+0.8%
0.25%
-36.2%
Q2 2022$379,148,000
-32.2%
8,378,971
+13.9%
0.39%
-0.8%
Q1 2022$559,552,000
-45.4%
7,355,764
+6.9%
0.39%
-30.2%
Q4 2021$1,024,603,000
+27.0%
6,878,377
+24.1%
0.56%
+33.2%
Q3 2021$806,896,000
-18.1%
5,542,625
+10.2%
0.42%
-12.1%
Q2 2021$985,169,000
+289.9%
5,030,996
+260.4%
0.48%
+240.4%
Q1 2021$252,698,000
+130.3%
1,396,126
+80.1%
0.14%
+131.1%
Q4 2020$109,743,000
+72.1%
775,020
+51.5%
0.06%
+38.6%
Q3 2020$63,767,000
+16506.0%
511,447
+11802.4%
0.04%
Q2 2020$384,000
+287.9%
4,297
+170.4%
0.00%
Q1 2020$99,0001,5890.00%
Other shareholders
10X GENOMICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 750,000$111,720,00099.68%
Foresite Capital Management II, LLC 1,753,528$261,206,00099.34%
Venrock Management VI, LLC 962,309$143,346,00096.17%
12 West Capital Management LP 2,004,000$298,516,00013.24%
FINANCIAL CONSULATE, INC 154,942$23,080,0008.00%
Meritech Capital Associates V L.L.C. 1,610,824$239,948,0007.68%
Andar Capital Management HK Ltd 55,000$8,193,0007.52%
JS Capital Management LLC 540,589$80,526,0003.66%
HARVARD MANAGEMENT CO INC 186,143$27,728,0002.60%
Connective Portfolio Management, LLC 7,000$1,056,0001.86%
View complete list of 10X GENOMICS INC shareholders